Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Submitted by
admin
on August 29, 2017 - 9:36am
Source:
Endpoints
News Tags:
Seattle Genetics
Genmab
antibody-drug conjugate
tisotumab vedotin
Headline:
Seven years in the making, Seattle Genetics picks up early option on Genmab’s ADC effort
Do Not Allow Advertisers to Use My Personal information
